Blog
May 2022 – The Data Driven Point of View Newsletter: Is Whole Exome or Whole Genome Sequencing Better?
...
FDA Safety Communication for Patients and Healthcare Providers on NIPS
...
April 2022 – The Data Driven Point of View Newsletter. FDA Oversight Needed So Lab Tests Do More GOOD than HARM
...
FDA Control of Laboratory Developed Tests (LDTs) Building Momentum with VALID Act
...
Natera and CareDx Fined Millions for False Advertising Associated with Inappropriate Marketing for Testing
...
Natera Minimal Residual Disease (MRD) Test Value Questioned by City of Hope for Colorectal Cancer Patients
...
March 2022 – The Data Driven Point of View Newsletter. False Positive Results are COMMON at Many Genetic Labs.
...
February 2022 – The Data Driven Point of View Newsletter. Laboratory Developed Test (LDT) vs. FDA-Approved Companion Diagnostic (CDx)
...
January 2022 – The Data Driven Point of View Newsletter. No FDA Regulation Exists for Prenatal Genetic Testing
...